Novartis Q1 sales beat gets help from weak dollar

1 分钟阅读

ZURICH, April 19 (Reuters) - Swiss drugmaker Novartis posted a 10 percent rise in first-quarter sales, more than analysts expected, as new Chief Executive Officer Vas Narasimhan got a boost from a weaker U.S. dollar and rising revenue from new medicines.

Core net income was $2.98 billion, the Basel-based company said in a statement on Thursday, equalling the average analyst forecast in a Reuters poll. Sales rose to $12.7 billion, compared to analyst forecasts that averaged $12.3 billion.